Value Sense
CLOV
Clover Health Investments, Corp. (CLOV)
Last Price$3.4(0.9%)
Market Cap$1,625.6M
LTM Selling, General & Administrative Expenses (SG&A)
$408.9M
YoY Growth
-7.5%
3Y CAGR
-2.8%
5Y CAGR
+24.7%
Stock quality & Intrinsic value
5/10
46.9% overvalued
CLOV
is (46.9%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Clover Health Investments, Corp. Selling, General & Administrative Expenses (SG&A)

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Selling, General & Administrative Expenses (SG&A)
$187.3M
$187.3M
$192.1M
$445.7M
$482.4M
$440.2M
$408.9M
CLOV
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CLOV and see if it's the right time to invest.
Dive in

Clover Health Investments, Corp. (CLOV) Selling, General & Administrative Expenses (SG&A) comparison analysis

General

LTM Selling, General & Administrative Expenses (SG&A)

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
$408.9M
(7.5%)
(2.8%)
24.7%
Median Peer Set
$2,249.5M
1.4%
5.8%
0.0%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
$53.5B
N/A
N/A
N/A
Cigna Corporation logo
Cigna CorporationCI
$14.8B
2.7%
4.8%
2.2%
Humana Inc. logo
Humana Inc.HUM
$13.2B
4.2%
9.3%
12.5%
Centene Corporation logo
Centene CorporationCNC
$12.4B
(1.3%)
6.8%
13.7%
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
$2,743.0M
11.4%
9.9%
16.2%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
$1,755.9M
416.9%
87.9%
N/A
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
$371.4M
20.8%
8.5%
N/A
Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
$260.0M
(55.5%)
(5.6%)
N/A
Elevance Health Inc. logo
Elevance Health Inc.ELV
$0.0
N/A
N/A
N/A
CVS Health Corporation logo
CVS Health CorporationCVS
($10.0M)
N/A
N/A
N/A

CLOV key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
281.0
0.0%
462.3
64.5%
672.9
45.6%
1,472.0
118.8%
1,096.6
(25.5%)
1,260.5
15.0%
1,371.1
8.8%
Cost of Goods Sold (COGS)0.0449.7590.11,551.2993.11,004.61,006.3
Gross Profit
% margin
281.0
100.0%
12.6
2.7%
82.8
12.3%
(79.2)
(5.4%)
103.5
9.4%
256.0
20.3%
364.8
26.6%
Operating Expenses476.0195.8175.5557.8390.1461.3410.6
Research & Development Expenses (R&D)0.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)187.3187.3192.1445.7482.4440.2408.9
Operating Income
% margin
(185.8)
(66.1%)
(183.2)
(39.6%)
(92.7)
(13.8%)
(637.0)
(43.3%)
(286.7)
(26.1%)
(205.3)
(16.3%)
(45.7)
(3.3%)
Interest Income7.00.00.10.00.00.00.0
Interest Expense0.039.157.116.91.40.00.0
Pre-tax Income(201.9)(363.7)(136.4)(587.8)(254.6)(210.1)(46.3)
Income Tax
% effective tax rate
(16.1)
8.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
Net Income
% margin
(201.9)
(71.9%)
(363.7)
(78.7%)
(136.4)
(20.3%)
(587.8)
(39.9%)
(339.6)
(31.0%)
(213.4)
(16.9%)
(43.0)
(3.1%)
EPS(4.81)(0.90)(0.23)(1.25)(0.71)(0.45)(0.08)
Diluted EPS(4.81)(0.90)(0.23)(1.25)(0.71)(0.45)(0.08)
EBITDA
% margin
(16.1)
(5.7%)
(324.1)
(70.1%)
(78.7)
(11.7%)
(569.6)
(38.7%)
(252.0)
(23.0%)
(207.6)
(16.5%)
(44.9)
(3.3%)

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Clover Health Investments, Corp.'s Selling, General & Administrative Expenses (SG&A)?

As of today, Clover Health Investments, Corp.'s last 12-month Selling, General & Administrative Expenses (SG&A) is $408.9M, based on the financial report for Dec 31, 2024 (Q4’2024).

2) What is Clover Health Investments, Corp.'s Selling, General & Administrative Expenses (SG&A) growth rate?

Over the last year, Clover Health Investments, Corp.'s Selling, General & Administrative Expenses (SG&A) growth was (7.5%). The average annual Selling, General & Administrative Expenses (SG&A) growth rates for Clover Health Investments, Corp. have been 16.5% over the past three years, 24.7% over the past five years.

3) Is Clover Health Investments, Corp.'s Selling, General & Administrative Expenses (SG&A) growth rate Good?

Over the last year, Clover Health Investments, Corp.'s Selling, General & Administrative Expenses (SG&A) growth was (7.5%), which is lower than industry growth of 1.8%. It indicates that Clover Health Investments, Corp.'s Selling, General & Administrative Expenses (SG&A) growth is Good.

4) How does Clover Health Investments, Corp.'s Selling, General & Administrative Expenses (SG&A) growth rate compare to its peers?

Over the last year, Clover Health Investments, Corp.'s Selling, General & Administrative Expenses (SG&A) growth was (7.5%), which is lower than peer median growth of 387.0%. The list of peers includes UNH, CI, HUM, CNC, MOH, OSCR, ALHC, BHG, ELV, CVS etc.